Menu

Dicerna Pharmaceuticals, Inc. DRNA

Full chart Compare
Set alert

Price alert · DRNA

All alert types
38.22 +38.22

Day range unavailable

52-week range unavailable

Revenue & Expenses

Other Income → Expenses: $481.00KExpenses → Selling, General & Admin: $72.13MExpenses → Research & Development: $205.38MExpenses → Interest Expense: $20.00KGross Profit → Expenses: $164.31MRevenue → Gross Profit: $164.31MNet Loss → Expenses: $112.75MOther Income$481.00KGross Profit$164.31MNet Loss$112.75MExpenses$277.54MSelling, General & Admin$72.13MResearch & Development$205.38MInterest Expense$20.00KRevenue$164.31M

Latest period ending Dec 31, 2020 · select a line to chart its full history

Annual income statement

DRNA annual income statement
Fiscal yearFY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017FY 2016 Dec 31, 2016
164.31M23.90M6.18M1.03M0
164.31M23.90M6.18M1.03M0
164.31M23.90M6.18M1.03M0
277.51M152.09M96.53M61.77M59.75M
205.38M109.34M45.71M35.89M41.40M
72.13M42.75M21.68M16.84M15.43M
-113.21M-128.19M-90.35M-60.74M-59.75M
20.00K3.00K603.00K00
-112.75M-120.46M-88.85M-60.20M-59.51M
-112.75M-120.46M-88.85M-80.29M-59.51M
-112.75M-120.46M-88.85M-80.29M-59.51M
-112.75M-120.46M-88.85M-60.20M-59.51M
-1.52-1.76-1.60-3.66-2.87
-1.52-1.76-1.60-3.66-2.87
-1.52-1.76-1.60-3.66-2.87
-112.73M-120.46M-88.25M-60.20M-59.51M
-112.73M-120.46M-88.25M-60.20M-59.51M
74.19M68.43M55.62M21.92M20.72M
74.19M68.43M55.62M21.92M20.72M